Fred W. Quimby. Dr. Quimby is a retired Professor of Pathology from Weill Medical College and the New York College of Veterinary Medicine, as well as, Professor of Immunology and Environmental Toxicology at Cornell University. He is also a retired Associate Vice President from The Rockefeller University. He has a continuing interest in improving methods for the diagnosis of infectious diseases in animals.
Michael G. Tokman. Dr. Tokman holds a PhD in Immunology and Toxicology from Cornell University. In addition to his scientific background, he brings many years of business development experience to Mastatix. His expertise lies in strategic planning, product development and marketing.
Andrew Neskoromnyi. Mr. Neskoromnyi is a veteran software developer and data analyst, who brings many years of computational analyses and computer engineering experience to Mastatix. His primary focus is to apply latest developments in the computer science field to solve complex biological problems.
mediantis AG. Founded in 1999, mediantis AG is a German publicly traded company with primary interest in establishing, managing and growing online business ventures. It offers financial contribution, while providing experienced counseling and advice. In his position as VP for International Business Ventures, Rolf von Rheinbaben has joined the Mastatix Management Team.